Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

@article{Scarabin2003DifferentialAO,
  title={Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk},
  author={P. Scarabin and E. Oger and G. Plu-Bureau},
  journal={The Lancet},
  year={2003},
  volume={362},
  pages={428-432}
}
BACKGROUND Oral oestrogen-replacement therapy (ERT) activates blood coagulation and increases the risk of venous thromboembolism (VTE) in postmenopausal women. Transdermal ERT has little effect on haemostasis, but data assessing its effect on thrombotic process are scarce. We aimed to examine the effect of the route of oestrogen administration on VTE risk. METHODS We did a multicentre hospital-based case-control study of postmenopausal women in France. During 1999-2002, we recruited 155… Expand
Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis.
Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis
  • P. Scarabin
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2018
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 24 REFERENCES
Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.
...
1
2
3
...